Psoriasis Clinical Trial

A Study of LY3471851 in Participants With Psoriasis

Summary

The main purpose of this study is to learn more about the safety and side effects of LY3471851 when given by injection just under the skin to participants with psoriasis. The study will last up to 48 weeks and may include up to 23 visits to the study center.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Have a confirmed diagnosis of psoriasis for at least 6 months
Have active psoriasis plaques according to study- specific criteria
Be willing and able to undergo skin biopsies

Exclusion Criteria:

Have received certain topical medications for psoriasis within 14 days prior to baseline
Have received certain systemic medications for psoriasis within 4 weeks prior to baseline
Have received LY3471851 previously

Study is for people with:

Psoriasis

Phase:

Phase 1

Estimated Enrollment:

30

Study ID:

NCT04119557

Recruitment Status:

Completed

Sponsor:

Nektar Therapeutics

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 24 Locations for this study

See Locations Near You

Arkansas Research Trials, LLC
North Little Rock Arkansas, 72117, United States
California Dermatology & Clinical Research Institute
Encinitas California, 92024, United States
Center For Dermatology Clinical Research, Inc.
Fremont California, 94538, United States
Therapeutics Clinical Research
San Diego California, 92123, United States
Clinical Science Institute
Santa Monica California, 90404, United States
Florida Academic Centers Research and Education, LLC
Coral Gables Florida, 33134, United States
Miami Dermatology and Laser Research
Miami Florida, 33173, United States
ForCare Clinical Research
Tampa Florida, 33613, United States
Medical Dermatology Specialists
Sandy Springs Georgia, 30328, United States
Dawes Fretzin Clinical Research Group, LLC
Indianapolis Indiana, 46250, United States
Skin Sciences
Louisville Kentucky, 40217, United States
Forefront Research
Louisville Kentucky, 40241, United States
Clinical Research Institute of Michigan, LLC
Chesterfield Michigan, 48047, United States
Derm Center
Troy Michigan, 48084, United States
Central Dermatology PC
Saint Louis Missouri, 63117, United States
ActivMed Practices and Research
Portsmouth New Hampshire, 03801, United States
Remington-Davis, Inc
Columbus Ohio, 43215, United States
Unity Clinical Research
Oklahoma City Oklahoma, 73118, United States
Paddington Testing Company Inc
Philadelphia Pennsylvania, 19103, United States
DermDox Centers for Dermatology
Sugarloaf Pennsylvania, 18249, United States
Studies in Dermatology, LLC
Cypress Texas, 77433, United States
Rodgers Dermatology
Frisco Texas, 75034, United States
Progressive Clinical Research
San Antonio Texas, 78229, United States
Complete Dermatology
Sugar Land Texas, 77478, United States

How clear is this clinincal trial information?

Study is for people with:

Psoriasis

Phase:

Phase 1

Estimated Enrollment:

30

Study ID:

NCT04119557

Recruitment Status:

Completed

Sponsor:


Nektar Therapeutics

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.